type 1 diabetes and glp 1 GLP-1 Agonists - What is it? GLP-1 Receptor Agonists as Treatments

10.1016/S0169-328X(01)00216-9 71 WangJ.BiM.LiuH.SongN.XieJ

reported exper- iments in which secretion could be induced directly in rat perito- Unlte d'lmmuno-Allergie, lnstltut Pasteur, Parls, France Received for publicatlnn March 31, 1997

According to literature, gut microbiota modulation might lead to a decline in fat storage in adipocytes due to incrementing fasting-induced adipose factor (FIAF) levels, a suppressor of lipoprotein lipase (LPL) (30), and foster lipid oxidation in the liver and muscles via amplified activity of adenosine monophosphate-activated protein kinase (AMPK) (30)

Start by preparing a solution of 5 mM fluorescein dissolved in BMHH